142 related articles for article (PubMed ID: 32016672)
21. [Application of dental floss traction-assisted endoscopic submucosa dissection to rectal neuroendocrine neoplasm].
Shi Q; Sun D; Zhong YS; Xu MD; Li B; Cai SL; Qi ZP; Ren Z; Zhang H; Yong YY; Yao LQ; Zhou PH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):377-382. PubMed ID: 31054553
[No Abstract] [Full Text] [Related]
22. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
23. Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report.
Tokumaru Y; Matsuhashi N; Takahashi T; Imai H; Tanaka Y; Okumura N; Yamaguchi K; Yoshida K
World J Surg Oncol; 2020 Apr; 18(1):74. PubMed ID: 32284069
[TBL] [Abstract][Full Text] [Related]
24. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
25. Rectal neuroendocrine tumors: Can they be observed?
Kramer SP; Tonelli C; Abdelsattar Z; Cohn T; Luchette FA; Baker MS
Surgery; 2023 Nov; 174(5):1161-1167. PubMed ID: 37661486
[TBL] [Abstract][Full Text] [Related]
26. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
[TBL] [Abstract][Full Text] [Related]
27. [Rectal neuroendocrine tumors: surgical therapy].
Radulova-Mauersberger O; Stelzner S; Witzigmannn H
Chirurg; 2016 Apr; 87(4):292-7. PubMed ID: 26888707
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.
Osagiede O; Habermann E; Day C; Gabriel E; Merchea A; Lemini R; Jabbal IS; Colibaseanu DT
J Gastrointest Oncol; 2020 Oct; 11(5):836-846. PubMed ID: 33209480
[TBL] [Abstract][Full Text] [Related]
30. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
31. Local versus Radical Excision of Early Distal Rectal Cancers: A National Cancer Database Analysis.
Melnitchouk N; Fields AC; Lu P; Scully RE; Powell AC; Maldonado L; Goldberg JE; Bleday R
Ann Surg Oncol; 2020 Jul; 27(7):2169-2176. PubMed ID: 31898098
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
33. [Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection].
Gu MG; Lee SH
Korean J Gastroenterol; 2018 Sep; 72(3):128-134. PubMed ID: 30270594
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.
Ko SH; Baeg MK; Ko SY; Jung HS
Surg Endosc; 2017 Oct; 31(10):3864-3871. PubMed ID: 28078467
[TBL] [Abstract][Full Text] [Related]
36. Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors.
Ushigome H; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
PLoS One; 2019; 14(2):e0211675. PubMed ID: 30742649
[TBL] [Abstract][Full Text] [Related]
37. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.
Li P; Wu F; Zhao H; Dou L; Wang Y; Guo C; Wang G; Zhao D
Int J Clin Exp Pathol; 2015; 8(10):13331-8. PubMed ID: 26722537
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic factor analysis of surgical treatment in patients with rectal neuroendocrine neoplasms].
Wu F; Li P; Zhao H; Liu S; Guo C; Wang Y; Zhao D
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1237-40. PubMed ID: 24924888
[TBL] [Abstract][Full Text] [Related]
40. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
